AKT1 and skin neoplasm: Given that the PI3K/Akt/mTOR signaling plays a crucial role in skin cancers, targeting this pathway with therapeutic nature-derived bioactive phytochemicals, biologic molecules, and synthetic small molecules alone or in various combinations is a promising strategy to treat skin cancers.